Concord Drugs Ltd to hold 31st AGM on Sep 30, 2026

Concord Drugs Ltd announced that its Board of Directors has approved the notice and proposed to hold the 31st Annual General Meeting (AGM) on September 30, 2026. The AGM will be conducted via Video Conferencing / Other Audio Visual Means. The Board also approved the Directors' Report and Annual Report for the financial year 2025-26. Key agenda items include the adoption of audited standalone and consolidated financial statements, re-appointment of directors retiring by rotation and independent directors, re-appointment of statutory auditors for a five-year term, and ratification of cost auditor remuneration. The company also approved seeking member approval for material related party transactions for FY 2026-27.